{{Rsnum
|rsid=896854
|Gene=TP53INP1
|Chromosome=8
|position=94948283
|Orientation=minus
|GMAF=0.4789
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=LOC101927002,TP53INP1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 21.8 | 43.6 | 34.5
| HCB | 11.8 | 39.7 | 48.5
| JPT | 14.2 | 36.3 | 49.6
| YRI | 55.8 | 38.1 | 6.1
| ASW | 40.4 | 52.6 | 7.0
| CHB | 11.8 | 39.7 | 48.5
| CHD | 9.2 | 37.6 | 53.2
| GIH | 12.1 | 55.6 | 32.3
| LWK | 57.8 | 39.4 | 2.8
| MEX | 15.8 | 49.1 | 35.1
| MKK | 29.5 | 55.8 | 14.7
| TSI | 22.5 | 49.0 | 28.4
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=20581827
|Trait=Type 2 diabetes
|Title=Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis
|RiskAllele=T
|Pval=1E-9
|OR=1.06
|ORtxt=[1.04-1.09]
|OA=1
}}

{{PMID Auto
|PMID=21278902
|Title=Genetic risk profiling for prediction of type 2 diabetes.
|OA=1
}}

{{PMID Auto
|PMID=23462794
|Title=Identification of CpG-SNPs associated with type 2 diabetes and differential DNA methylation in human pancreatic islets.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}